Tradjenta now available in U.S. pharmacies
INDIANAPOLIS — A new oral medication for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim has become available in pharmacies, the companies said Wednesday.
Lilly and BI announced the availability of Tradjenta (linagliptin) in chain and independent pharmacies around the country.
The Food and Drug Administration approved the drug at the beginning of May, though Lilly ran into trouble when Amylin Pharmaceuticals, with which it developed and markets the injected Type 2 diabetes drug Byetta (exenatide), sued Lilly in federal court in an attempt to keep it from using the same sales force to sell both drugs. Amylin alleged that using the same sales force would violate their Byetta agreement because the drugs would compete, but a judge threw out Amylin’s claims.
“The rapid availability of Tradjenta for adults with Type 2 diabetes following FDA approval is a testament to Boehringer Ingelheim and Lilly’s joint commitment to improving patient care,” Boehringer Ingelheim Pharmaceuticals VP cardiovascular and metabolic disorders Wa’el Hashad said. “The health of patients is our first priority, and we work diligently to ensure our medications are accessible for patients. With just once dose to remember for all patients, Tradjenta is an important new treatment option that could help the millions of Americans living with Type 2 diabetes.”
No comments found
Good Neighbor to ‘lend a hand’ to local charities
VALLEY FORGE, Pa. — The “Today Show” special program “Lend a Hand” will get a hand from one of the country’s largest independent pharmacy networks.
Good Neighbor Pharmacy is supporting the program, which started Monday and continues through Friday. During the program, weatherman Al Roker will travel to Anchorage, Alaska; Houston; Birmingham, Ala.; and Charleston, W.Va., to help local charities.
Good Neighbor Pharmacy, which includes 3,700 independent pharmacies around the country, will supply first-aid kits, personal care items, bottled water and other products based on the charities’ needs, as well as financial donations.
Video of the stops is available at Youtube.com/goodneighborpharmacy.
No comments found
Dr. Reddy’s subsidiary confirms receipt of FDA warning letter
HYDERABAD, India — The Food and Drug Administration has issued a warning letter to Dr. Reddy’s Labs’ chemical manufacturing plant in Mexico, the company said Tuesday.
The drug maker said Dr. Reddy’s subsidiary Industrias Quimicas Falcon de Mexico, in Cuernavaca, received an FDA warning letter based on a November 2010 inspection where the regulatory agency found a number of manufacturing problems.
Dr. Reddy’s said it takes the warnings seriously and will respond to the FDA and work with the agency to resolve the problems.
And you wonder why I ask the pharmacy which country is my meds being made in? I won't take anything thats made in Mexico or India. I WILL CONTINUE TO SPEND MY MONEY ON USA PRODUCTS WHICH AS WE SEE ARE MORE HIGHLY REGULATED AND PRIDEFULLY MADE. I hope that others are doing the same to bring back jobs to OUR country!